Los Angeles R&D Tax Credit for Businesses Explained

R&D Tax Credits for Los Angeles, California Businesses

Los Angeles, California, is a global hub for industries such as entertainment, technology, healthcare, aerospace, and fashion. Top companies in the city include The Walt Disney Company, a leading entertainment company; SpaceX, a prominent aerospace manufacturer; Cedars-Sinai Medical Center, a major healthcare provider; Snap Inc., a key technology company; and Northrop Grumman, a major defense contractor. The Research and Development (R&D) Tax Credit can help these industries reduce their tax liabilities, foster innovation, and enhance business performance.

find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 115 W California Boulevard, Pasadena is less than 10 miles from Los Angeles and provides R&D tax credit consulting and advisory services to Los Angeles and the surrounding areas such as: Long Beach, Santa Ana, Anaheim, Glendale and Torrance.

If you have any questions or need further assistance, please call or email our local Pasadena Partner on (323) 287-5311.
Feel free to book a quick teleconference with one of our California R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Los Angeles, California Patent of the Year – 2024/2025

Black Light Surgical Inc. and Cedars-Sinai Medical Center has been awarded the 2024/2025 Patent of the Year for their innovation in real-time tissue diagnostics. Their invention, detailed in U.S. Patent No. 12025557, titled ‘Systems, devices, and methods for time-resolved fluorescent spectroscopy’, employs time-resolved fluorescent spectroscopy to analyze biological tissues both in vivo and ex vivo.

This technology utilizes a light source to emit pulses that excite the tissue, inducing a fluorescent response. A demultiplexer then splits this signal into multiple spectral bands, each delayed in time, allowing a detector to capture comprehensive data from a single excitation pulse. By analyzing the intensity and decay of these spectral bands, the system can characterize the tissue’s properties in real-time.

The device features a two-piece probe design with a detachable, disposable distal end, enhancing hygiene and ease of use. It can be integrated with other optical spectroscopy or imaging modalities, providing a versatile tool for medical diagnostics.

Clinically, this advancement holds promise for improving the accuracy of tissue characterization during surgical procedures, potentially aiding in the detection of abnormalities such as tumors. Its real-time analysis capability could lead to more informed decision-making in the operating room, enhancing patient outcomes.

The development of this technology underscores the potential of combining advanced spectroscopy with practical medical applications, marking a significant step forward in diagnostic methodologies.